Héctor Alejandro Vaquera-Alfaro

6PUBLICATIONS
22CO-AUTHORS
Haematological tumoursMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2025
Aggressive Sternum Extension in Diffuse Large B-Cell Lymphoma: Barriers to Timely Care in a Resource-Limited Setting.

Anahí Morales-Pedraza, Zulia Guzmán-Martínez, Ana C Tejada-Vásquez

|Apr 17, 2025
Prevalence of medical writing in hematological malignancy review articles.

Héctor A Vaquera-Alfaro, Elham Nasrollahi, Yashvin Onkarappa Mangala

|Nov 24, 2024
Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study.

Perla R Colunga-Pedraza, Fernando De la Garza-Salazar, Héctor A Vaquera-Alfaro

|Nov 19, 2024
Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma.

Perla R Colunga-Pedraza, Héctor A Vaquera-Alfaro, Zulia Guzmán-Martínez

|Nov 11, 2024
[Epidemiological characteristics in gastroenteritis diagnosis before and during the pandemic].

Claudia Marcela Martínez-Salinas, Héctor Alejandro Vaquera-Alfaro, Neri Alejandro Álvarez-Villalobos

|Oct 06, 2024
Transplant in myeloma: individualized approaches needed depending on context, access and biology.

Héctor A Vaquera-Alfaro, Andrés Gómez-De León, Nihar Desai

Pageof 1